[1]Siegel, Miller, Fuchs, et al. Cancer Statistics, 2021[J]. CA Cancer J Clin,2021,71(1):7-33.
[2]刘彧,童清平,连娟,等. 乳腺癌弹性超声特征与分子生物学指标的相关性研究[J]. 东南国防医药,2015(2):116-118.
[3]Paplomata E, O Regan R. The PI3K/AKT/Mtor path-way in breast cancer: targets, trials and biomarkers[J]. Ther Adv Med Oncol, 2014,6(4):154-166.
[4]Kim JH, Bae SC. Histone deacetylase inhibitors: molecular mechanisms of action and clinical trials as anti-cancer drugs[J]. Am J Transl Res,2011,3(2) : 166-179.
[5]权恺,刘群,李萍,等.人参皂苷抗癌活性的最新研究进展[J]. 医学研究生学报,2015,28(4):427-431.
[6]黄社霄.人参、西洋参、三七药用探讨[J]. 中国中医药现代远程教育,2011,9(15):73-74.
[7]Zhang G, Liu A, Zhou Y, et al. Panax ginsengginsenoside-Rg2 protects memory impairment via anti-apoptosis in a rat model with vascular dementia [J]. J Ethnopharmacol, 2008,115 (3):441-448.
[8]Yu XT, Wang SP. Clinical ob servation on treatment for postoperative gastric cancer by ginsenoside Rg3 combined with chemotherapy [J]. Chin J Cancer Prev Treat,2010,17(10): 779-781.
[9]William CS, Chung WS, Sally KW, et al. Ginsenoside Re of Panax ginseng possesses significant antioxidant and antihyperlipidemic efficacies in streptozotocin-induced diabetic rats [J]. Eur J Pharmacol, 2006,550(1-3): 173-179.
[10]Kim SE, Lee YH,Park HJ,et al. Ginsenoside-Rs4, a new type of ginseng saponin concurrently induces apoptosis and selectively elevates protein levels of p53 and p21 WAF1 in human hepatoma SK-HEP-1 cells European [J]. Eur J Cancer, 1999,35(3):507-511.
[11]唐立,徐惠亮,郝双影.人参皂苷Rg3调控lncRNA-LINP1抑制胃癌细胞生长的作用机制[J]. 医学研究生学报,2020,33(11):1157-1160.
[12]董叶萍,周心怡,费思力,等.肝细胞癌细胞中差异表达环状RNA与microRNA-1相关的生物信息学分析[J]. 医学研究生学报,2020,33(3):246-250.
[13]童也,王宇翔,徐海栋.基于生物信息学方法的椎间盘退变miRNA芯片数据[J]. 医学研究生学报,2019,32(9):904-909.
[14]陈娟,刘传丽,陈艳思,等. IL-17A在卵巢癌中的表达水平及潜在机制的生物信息学分析[J]. 东南国防医药,2020,22(1):25-29.
[15]吴波,黄盛璟,邢婧,等.基于网络药理学的复方当归注射液治疗缺血性脑损伤作用机制分析[J]. 中国医院药学杂志, 2019,39(23):2384-2389.
[16]宋雪,司徒红林,林毅.林毅运用扶正祛邪法辩治复发转移性乳腺癌经验介绍[J]. 新中医,2017,49(6):177-178.
[17]朴丽花,蔡英兰,张默函,等.人参皂苷经PI3K/AKT通路诱导乳腺癌细胞凋亡[J]. 临床与实验病理学杂志,2013,29(9):946-948.
[18]王楠,廖莎,陈璐,等.人参皂苷Rb1对人乳腺癌MDA-MB-231细胞上皮-间质转化及ROR1表达的影响[J]. 中国药业,2020,29(21):25-28.
[19]陈军.人参皂苷对小鼠晚期乳腺癌模型的抑瘤作用[J]. 新乡医学院学报,2015, 32(12):1091-1094.
[20]董周威,王启威,张丽萍,等.利用生物信息技术分析喉癌的关键基因[J]. 医学研究杂志,2021,50(1):97-103.
[21]刘怀全,周芳芳,张玉佩,等.生物信息学在中西医结合基础研究汇总的应用前景[J]. 湖北民族大学学报(医学版),2020,37(2):49-52.
[22]Rahman MA, Toi M. Anti-angiogenic therapy in breast cancer[J]. Biomed Pharmacother, 2003, 57(10):463-470.
[23]Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis.[J]. Cell, 1996, 86(3):353-364.
[24]Gabriela LM, NM Pía, Tatiana PL, et al. Autoantibodies against Muscarinic Receptors in Breast Cancer: Their Role in Tumor Angiogenesis[J]. PLoS One, 2013, 8(2):e57572.
[25]赵伟博.基于非标记蛋白质组学不同淋巴结状态乳腺癌预后的候选血浆生物标志物筛选[D]. 无锡:江南大学,2019.
[26]胡雷,孙硕,毛露,等.尿激酶型纤溶酶原激活物系统作为乳腺癌预后生物标志物的展望[J]. 医学理论与实践,2020,33(1):30-32.
[27]毕薇薇,车轶群,李振家. 富含半胱氨酸的分泌型酸性蛋白与肿瘤的关系[J]. 国外医学,2005,26(8):551-552.
[28]朱璐.富含半胱氨酸的酸性分泌蛋白与恶性肿瘤[J]. 国际肿瘤学杂志,2010, 37(7):504-507.
[29]张婷婷,刘勇军,梁爱玲.微小RNA与乳腺癌[J]. 国际肿瘤学杂志,2014,41(1):37-40.